CWA
ANIX icon

Continuum Wealth Advisors’s Anixa Biosciences ANIX Stock Holding History

Continuum Wealth Advisors’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$40.3K Buy
+13,752
New +$44.2K 0.01% 76

Other funds holding ANIX

CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
Gemmer Asset Management
Gemmer Asset Management Walnut Creek, California $1.53B AUM 31.12% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Robertson Stephens Wealth Management
Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return
CCIA
Cherry Creek Investment Advisors Englewood, Colorado $261M AUM 29.65% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Continuum Wealth Advisors's ANIX Position: Q3 2026 in Review

Continuum Wealth Advisors opened a new position in Anixa Biosciences (ANIX) in Q3 2026: 13,752 shares worth $40.3K. The stake represents 0.01% of the portfolio and ranks #76 among its holdings.

7 funds tracked by Wall St. Rank hold ANIX as of Q3 2026.

  • Continuum Wealth Advisors held 13,752 shares of Anixa Biosciences worth $40.3K as of Q3 2026.
  • Anixa Biosciences was a new Continuum Wealth Advisors position in Q3 2026.
  • Anixa Biosciences made up 0.01% of Continuum Wealth Advisors's portfolio in Q3 2026, its #76 holding.
  • 7 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2026.

Based on Continuum Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.